BK-MDA
$16.00
3,4-Methylenedioxycathinone (other names: BK-MDA, MDC, Nitrilone, Amylone) is a stimulant drug of the class of cathinones and amphetamines, a homologue of cathinone and the β-keto analogue of MDA.
This drug was developed as an antiparkinsonian drug, but has found applications in medicine.
This drug can cause effects similar to MDA, such as stimulation, increased workability, energy, insomnia, dilated pupils, euphoria.
You can buy BK-MDA online at a price:
QUANTITY | Disc (%) | Price per gram |
1 g | – | – |
2 g | 0 % | 16.00 |
5 g | 31 % | 11.00 |
10 g | 43 % | 9.00 |
25 g | 56 % | 7.00 |
50 g | 68 % | 5.00 |
100 g | 79 % | 3.30 |
250 g | 83 % | 2.60 |
500 g | 85 % | 2.30 |
1000 g | 88 % | 1.80 |
Description
3,4-Methylenedioxycathinone (other names: BK-MDA, MDC, Nitrilone, Amylone) is a stimulant drug of the class of cathinones and amphetamines, a homologue of cathinone and the β-keto analogue of MDA.
This drug was developed as an antiparkinsonian drug, but has found applications in medicine.
Chemistry
3,4-Methylenedioxycathinone is an analogue of cathinone and MDA, and has a related chemical structure.
Pharmacology
This substance has been little studied and there is little data on its pharmacological and toxicological properties.
All the data presented are based on data from studies on rodents.
This drug can cause effects similar to MDA, such as stimulation, increased workability, energy, insomnia, dilated pupils, euphoria.
Legal status
UK: Class B.
Product Name: BK-MDA
Other Name(s): 3,4-Methylenedioxycathinone, βk-MDA, MDC, Nitrilone, Amylone
IUPAC Name: (±)-2-amino-1-(3,4-methylenedioxyphenyl)propan-1-one
CAS: 80535-73-5
Molar Mass: 193.20 g/mol
Molecular Formula: C10H11NO3
InChi Code: InChI=1S/C10H11NO3/c1-6(11)10(12)7-2-3-8-9(4-7)14-5-13-8/h2-4,6H,5,11H2,1H3
InChIKey: XDEZOLVDJWWXRG-UHFFFAOYSA-N
Canonical SMILES: CC(C(=O)C1=CC2=C(C=C1)OCO2)N
Formulation: A solid, Crystals
Create a preliminary purchase request. Check stock availability. Communication with support:
Reviews
There are no reviews yet.